As of Nov 19, 2026, 1 of 1 active firms rate CRON a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
CRON EPS & revenue forecast
EPS · NEXT QUARTER
$0.07
Range $0.04 – $0.09 · 3 analysts · +21% YoY
Next period, 3 analysts expect Cronos Group Inc to earn $0.07 a share (range $0.04 – $0.09), versus $0.05 a year earlier. Full-year consensus is $0.26, growing to $0.25 the year after.
REVENUE · NEXT QUARTER
$95.5M
Range $87.7M – $100.9M · 3 analysts · +54% YoY
Revenue is expected to reach $95.5M (range $87.7M – $100.9M), +54.3% year-over-year. Full-year consensus is $322.1M, rising to $399.4M next year.
Top analysts covering Cronos Group Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CRON.
#1
PZ
Pablo Zuanic
Zuanic & Associates
Buy
No targeton CRON
Coverage
—
+ Follow
#2
NS
Nadine Sarwat
Bernstein
Neutral
$3.45+8.8% to target
Coverage
—
+ Follow
#3
Bill Kirk
Roth MKM
Buy
$5.00+57.7% to target
Coverage
—
+ Follow
#4
KT
Kenric Tyghe
Canaccord Genuity
Buy
$4.25+34.1% to target
Coverage
—
+ Follow
CRON stock forecast FAQ
Is CRON stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 1 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover CRON?+
1 active firms have a recognized rating on Cronos Group Inc as of Nov 19, 2026.
Who is the most accurate analyst covering CRON?+
Among analysts who currently cover CRON, Pablo Zuanic of Zuanic & Associates has the strongest overall Quantellect track record. Their current call is Buy.
What is Cronos Group Inc's projected EPS for next quarter?+
The consensus estimate is $0.07 per share (range $0.04 – $0.09) across 3 analysts. Full-year EPS is projected at $0.26, rising to $0.25 the following year.
How much revenue is Cronos Group Inc expected to report next quarter?+
Consensus revenue is $95.5M (range $87.7M – $100.9M). Full-year revenue is projected at $322.1M, growing to $399.4M next year.
Have analysts been upgrading or downgrading CRON lately?+
As of Nov 19, 2026, 1 of 1 active firms rate CRON a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CRON calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.